Norfolk, VANCT07160634Now EnrollingIRB Ready

Duchenne Muscular Dystrophy Clinical Trial in Norfolk, VA

Access cutting-edge duchenne muscular dystrophy treatment through this clinical trial at a research site in Norfolk. Study-provided care at no cost to qualified participants.

Sponsored by Solid Biosciences Inc.

Quick Self-Assessment

See if you qualify for this Norfolk location

Preparing your pre-screening questions…

Expert Care in Norfolk

Access duchenne muscular dystrophy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related duchenne muscular dystrophy treatment provided free

Apply for This Norfolk Location

Check if you qualify for this duchenne muscular dystrophy clinical trial in Norfolk, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Norfolk

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Norfolk site if eligible
  4. 4Begin participation

About This Duchenne Muscular Dystrophy Study in Norfolk

This is a Phase 3, double-blind, placebo-controlled study with the primary objective of evaluating the efficacy of a single IV infusion of SGT-003 in pediatric ambulant male participants with DMD. The secondary objectives include the evaluation of additional efficacy and safety outcomes. The study will be divided into 2 parts. Participants will be randomized 1:1 to either SGT-003 in Part 1 followed by placebo in Part 2 or to placebo in Part 1 followed by SGT-003 in Part 2. Participants will continue to be monitored in long term follow up (LTFU) for at least 5 years from their SGT-003 dosing date.

Sponsor: Solid Biosciences Inc.

Who Can Participate

Inclusion Criteria

Participant is ambulatory.
Established clinical diagnosis of DMD and documented DMD gene mutation predictive of DMD phenotype.
Negative for antibodies against adeno-associated virus.
On a stable daily oral regimen of at least 0.5 mg/kg/day prednisone or 0.75 milligrams per kilogram per day (mg/kg/day) deflazacort for at least 6 months prior to entering the study, allowing for weight-based dose modifications in accordance with clinical practice.
Meet 10-meter walk/run time criteria.
Meet time to rise from supine criteria.
Participant has bodyweight ≤50 kg.

Exclusion Criteria

Current or prior treatment with an approved or investigational gene transfer drug or gene editing therapy.
Exposure to vamorolone, givinostat, approved or investigational dystrophin- or disease-modifying drugs (such as eteplirsen, golodirsen, casimersen, viltolarsen, and ataluren), or another investigational drug for any indication within 6 months or 5 half-lives, whichever is longer, prior to enrollment.
Established clinical diagnosis of DMD that is associated with any deletion variant or variant predicted not to express exons 1 to 11, exons 42 to 45, or exons 57 to 69, inclusive of the DMD gene as documented by a genetic report. Other Inclusion/Exclusion criteria to be applied as per protocol.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Norfolk?

Yes, this clinical trial (NCT07160634) has an active research site in Norfolk, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Duchenne Muscular Dystrophy Treatment Options in Norfolk, VA

If you're searching for duchenne muscular dystrophy treatment options in Norfolk, VA, this clinical trial (NCT07160634) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Norfolk research site is actively enrolling participants for this clinical trial. You'll receive care from experienced duchenne muscular dystrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all duchenne muscular dystrophy clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Norfolk, VA

See all ulcerative colitis clinical trials recruiting in Norfolk — not just this study.

Browse Ulcerative Colitis Trials in Norfolk →

Browse More Trials by Condition

Ulcerative Colitis TrialsPulmonary Hypertension TrialsDuchenne Muscular Dystrophy TrialsAll Conditions →

Ready to Join in Norfolk?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Norfolk, VA